N J Laping Selected Research

Carcinoma (Carcinomatosis)

7/2002

Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N J Laping Research Topics

Disease

2	Fibrosis (Cirrhosis) 03/2008 - 11/2001
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2008
1	Disease Progression 03/2008
1	Carcinoma (Carcinomatosis) 07/2002
1	Stroke (Strokes) 11/2001
1	Proteinuria 11/2000
1	Renal Insufficiency (Renal Failure) 11/2000
1	Hypertension (High Blood Pressure) 11/2000
1	Alzheimer Disease (Alzheimer's Disease) 01/2000

Drug/Important Bio-Agent (IBA)

3	Transforming Growth Factor beta (TGF-beta)IBA 03/2008 - 11/2000
3	Messenger RNA (mRNA)IBA 03/2008 - 11/2000
2	CollagenIBA 11/2001 - 11/2000
2	Fibronectins (Fibronectin)IBA 11/2001 - 11/2000
1	Phosphotransferases (Kinase)IBA 03/2008
1	4- (4- (3- (pyridin- 2- yl)- 1H- pyrazol- 4- yl)pyridin- 2- yl)- N- (tetrahydro- 2H- pyran- 4- yl)benzamideIBA 03/2008
1	p38 Mitogen-Activated Protein KinasesIBA 07/2002
1	SB 242235IBA 07/2002
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 07/2002
1	Carvedilol (Coreg)FDA LinkGeneric 11/2001
1	Proteins (Proteins, Gene)FDA Link 11/2001
1	SaltsIBA 11/2001
1	Plasminogen Activator Inhibitor 1IBA 11/2000
1	eprosartan (Teveten)FDA Link 11/2000
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2000
1	ThrombospondinsIBA 11/2000
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2000
1	Peptides (Polypeptides)IBA 01/2000

Therapy/Procedure

1	Oral Administration 03/2008
1	Nephrectomy 11/2000